Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Medical and Pharmaceutical Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results Analysts at Cantor Fitzgerald and JP Morgan Chase & Co recently gave the company an overweight rating Rowan DunneOctober 25, 2024
Health & Wellness AstraZeneca to expand US manufacturing for cell therapy Investment in AstraZeneca's new Rockville Facility to propel cancer treatment research and development Zartasha MushtaqFebruary 12, 2024
Health & Wellness GSK acquires late-stage Canadian biopharma company BELLUS Health for USD$2B Approximately 28 million patients suffer from refractory chronic cough Joseph MortonApril 20, 2023
Medical and Pharmaceutical The Mugglehead technology roundup: medical tech and biotechnology edition Here are five biotechnology and medical tech companies pooling their resources to make our lives easier. Joseph MortonOctober 14, 2022
Crypto/Blockchain The Mugglehead technology roundup: forward progress edition Here are five companies trying to find their own ways into our consciousness Joseph MortonJune 30, 2022
Crypto/Blockchain The Mugglehead technology roundup: the good news edition Today's Mugglehead technology roundup features five companies either providing good news or receiving good news. Joseph MortonJune 27, 2022
Business Avicanna reports record $1M in sales The firm is selling in 12 international markets and has added eight more product listings in Canada Kathryn TindaleNovember 12, 2021